NEW YORK (360Dx) – The Magellan Diagnostics business unit of Meridian Bioscience has signed an exclusive distribution agreement with MedCaptain Medical Technology for distribution of Magellan's LeadCare II blood lead testing system in Chinese markets. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.